Evaluation of the effect of a neuromuscular blocker in patients undergoing gastric bypass surgery by videolaparoscopy

Not Applicable

• Conditions: Obesity; Postoperative Pain; Gastric Bypass; E02.650.500.062

• Registration Number: RBR-6g2vcnx
• Lead Sponsor: Hospital São Domingos

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-12-31
• Study Start: 2024-05-21
• Last Update Posted: 25 June 2024

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

aged between 18 and 65 years, both sexes, with an ASA score from 1 to 3, undergoing roux-en-y gastric bypass by robotic surgery will be included in the study.

Exclusion Criteria

Patients with cardiac arrhythmias, dilated cardiomyopathy, cardiac conduction disorder, electrolyte disturbance, acid base disturbance, known or suspected allergies to drugs used during anesthesia, family history of neuromuscular disease, family history of malignant hyperthermia, and renal failure, psychiatric, hepatic, respiratory or oncological diseases, who are receiving any type of analgesic in the week before surgery and those who receive blood products during the study period.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients in the sustained deep neuromuscular blockade group are expected to obtain better surgical conditions with reduced postoperative pain and consequently lower postoperative pain scores. Assessment will be performed using questionnaires at defined times to check pain intensity, time of first request for opioid use and total opioid consumption in the first 24 hours.

Secondary Outcome Measures

Name	Time	Method
o secondary results expected